CDMO Blog

close

Subscribe to Email Updates

Popular Stories

Viral Aggregation in Downstream Processing of Lentiviral Vectors
IQ, OQ and PQ: Why Are They Important in the Manufacturing of Cell and Gene Therapies?
5 Considerations for Scaling-Up PSC-Derived Cell Therapies
Five Steps to Ensure Your Cell and Gene Therapy Product Is GMP Compliant
What is a Bioreactor and How is it Used in Cell and Gene Therapy?
03 Aug 2021

CCRM Collaborates To Tighten Timelines and Prepare Nkarta for IND Filing

CCRM works with customers in a collaborative manner to enable them to ...

27 Jul 2021

3 Ways Your CDMO Can Help You Avoid Supply Chain Problems

The COVID-19 pandemic has significantly disrupted supply chains and pr...

12 May 2021

How CCRM's Unique Approach Enables Client Success

Outsourcing to a contract development and manufacturing organization (...

01 Dec 2020

3 Considerations When Developing Your LVV Program

If you are looking to get a lentiviral vector (LVV) program off the gr...

12 Aug 2020

CDMOs: The Good, the Great and the Exceptional (and How to Tell the Difference)

Outsourcing to a contract development and manufacturing organization (...

17 Apr 2020

Quality-by-Design Approach to Manufacturing Cell and Gene Therapies

Implementation of a manufacturing process that assures a predefined qu...

27 Mar 2020

Essentials of Auditing in the Manufacturing of Cell and Gene Therapies

Our previous posts on quality management systems and steps to ensure y...

13 Feb 2020

Understanding Cryopreservation of Cellular Therapies

Cryopreservation is the process of using ultra-low temperatures to pre...

29 Jan 2020

Induced Pluripotent Stem Cells – Understanding Reprogramming

Stemming (pun intended) from the fundamental question in developmental...

10 Jan 2020

Road to success: Understanding Good Laboratory Practice for cell and gene therapies

Good Laboratory Practice (GLP) studies are essential for generating no...

Tell us what you thought about this post.